{
    "code": "91000701",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=91000701",
    "time": "2020-02-26 10:08:47",
    "許可證字號": "衛部藥陸輸字第000701號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "109\/10\/22",
    "發證日期": "104\/10\/22",
    "許可證種類": "原料藥",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA09100070105",
    "中文品名": "鹽酸邁杜蔥酮",
    "英文品名": "Mitoxantrone Hydrochloride",
    "適應症": "抗腫瘤藥",
    "劑型": "040（粉）",
    "包裝": "20公克以上裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "01製劑原料",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "",
    "限制項目": "02輸　入 40大陸生產",
    "申請商名稱": "0801701100  東信化學藥品有限公司",
    "申請商地址": "台北市吉林路４５號６樓",
    "主製造廠": [
        {
            "製造廠名稱": "FCN0619000  CHONGQING CARELIFE PHARMACEUTICAL CO., LTD.",
            "製造廠廠址": "3 HUA NANYI ROAD, CHONGQING (CHANGSHOU) CHEMICAL INDUSTRY PARK, CHONGQING, CHINA",
            "製造廠公司地址": "",
            "製造廠國別": "CHINA",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [],
    "仿單外盒": [
        {
            "title": "Mitoxantrone HCL (衛部藥陸輸字第000701號)-104-11-09.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=91000701&Seq=001&Type=9"
        }
    ]
}